Literature DB >> 21329406

Rethinking aphasia therapy: a neuroscience perspective.

Rosemary Varley1.   

Abstract

This article explores how consideration of acquired speech and language disorders from the perspective of neuroscience permits new insights into the content and design of therapy for people with aphasia. Key proposals are that aspects of current therapies often neglect the sensory-motor components of speech and language processing, and the interconnectivity of sensory-perceptual and motor systems. Furthermore, current therapy regimes are often administered at too low an intensity to stimulate neural reorganization. Neuroscientific perspectives on learning are explored and in particular the issues of associationist learning, learned misuse, mirror neurone systems, and procedural and errorless learning. The value of use of computer programs in administering high intensity therapy is outlined and it is proposed that aphasia therapies can be enhanced if clinicians adopt an explicit neuroscientific rationale for intervention.

Entities:  

Mesh:

Year:  2011        PMID: 21329406     DOI: 10.3109/17549507.2010.497561

Source DB:  PubMed          Journal:  Int J Speech Lang Pathol        ISSN: 1754-9507            Impact factor:   2.484


  3 in total

1.  The impact of dose on naming accuracy with persons with aphasia.

Authors:  Catherine A Off; Jenna R Griffin; Kristie A Spencer; Margaret Rogers
Journal:  Aphasiology       Date:  2016-10-16       Impact factor: 2.773

Review 2.  What is Functional Communication? A Theoretical Framework for Real-World Communication Applied to Aphasia Rehabilitation.

Authors:  W J Doedens; L Meteyard
Journal:  Neuropsychol Rev       Date:  2022-01-25       Impact factor: 7.444

3.  Comparison of Therapy Practice at Home and in the Clinic: A Retrospective Analysis of the Constant Therapy Platform Data Set.

Authors:  Jason Godlove; Veera Anantha; Mahendra Advani; Carrie Des Roches; Swathi Kiran
Journal:  Front Neurol       Date:  2019-02-25       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.